CNS Pharmaceuticals, Inc. (CNSP) › EPS (Diluted)CNS Pharmaceuticals, Inc. (CNSP) — EPS (Diluted)Annual figures by period end, from SEC filings.2021-12-31: $-16.502022-12-31: $-11.222023-12-31: $-12509.112024-12-31: $-466.892025-12-31: $-35.75$-35.752021-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-35.75—2026-03-31From 2025-01-012024-12-31$-466.89—2026-03-31From 2024-01-012023-12-31$-12509.11—2025-03-31From 2023-01-012022-12-31$-11.22—2024-04-01From 2022-01-012021-12-31$-16.50—2023-03-31From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)